deuterated dextromethorphan with quinidine
Showing 1 - 25 of 186
Drug-drug Interaction Trial in Melbourne (AVP-786, Paroxetine, Duloxetine)
Completed
- Drug-drug Interaction
- AVP-786
- +2 more
-
Melbourne, Victoria, AustraliaNucleus Network
Feb 15, 2022
Huntington Disease, Irritability Trial in Houston (Dextromethorphan/quinidine 20mg/10mg (DM/Q 20mg/10mg), Placebo)
Recruiting
- Huntington Disease
- Irritability
- Dextromethorphan/quinidine 20mg/10mg (DM/Q 20mg/10mg)
- Placebo
-
Houston, TexasThe University of Texas Health Science Center at Houston
Feb 21, 2022
Disinhibition Syndrome Trial in Las Vegas (AVP-786, Placebo)
Terminated
- Disinhibition Syndrome
- AVP-786
- Placebo
-
Las Vegas, NevadaCleveland Clinic Lou Ruvo Center for Brain Health
Oct 1, 2020
Agitation, Alzheimer's Disease Trial in United States (AVP-923-20, Placebo, AVP-923-30)
MDD Trial in Bhubaneswar (Selective Serotonin Reuptake Inhibitors, Dextromethorphan, Placebo)
Recruiting
- Major Depressive Disorder
- Selective Serotonin Reuptake Inhibitors
- +2 more
-
Bhubaneswar, Odisha, IndiaAll India Institute of Medical Sciences (AIIMS)
Feb 11, 2022
Amyotrophic Lateral Sclerosis Trial in Fort Lauderdale, Gainesville (dextromethorphan HBr and quinidine sulfate)
Completed
- Amyotrophic Lateral Sclerosis
- dextromethorphan HBr and quinidine sulfate
-
Fort Lauderdale, Florida
- +1 more
Nov 23, 2021
Alzheimer's Disease, Pseudobulbar Affect (PBA) Trial in Phoenix (Nuedexta (20/10))
Terminated
- Alzheimer's Disease
- Pseudobulbar Affect (PBA)
- Nuedexta (20/10)
-
Phoenix, ArizonaBarrow Neurological Institute
Oct 25, 2019
Treatment Resistant Schizophrenia Trial in Bhubaneswar (Dextromethorphan, Placebo)
Not yet recruiting
- Treatment Resistant Schizophrenia
- Dextromethorphan
- Placebo
-
Bhubaneswar, Odisha, IndiaAll India Institute of Medical Sciences (AIIMS)
Jul 15, 2023
Agitation in Patients With Dementia of the Alzheimer's Type Trial in Worldwide (AVP-786)
Recruiting
- Agitation in Patients With Dementia of the Alzheimer's Type
-
Chandler, Arizona
- +240 more
Aug 23, 2022
Trypanosomiasis, African Trial in Kuala Lumpur (Acoziborole, Midazolam, Dextromethorphan)
Completed
- Trypanosomiasis, African
- Acoziborole
- +2 more
-
Kuala Lumpur, MalaysiaClinical Research Center (CRC) Ampang Hospital
Jul 7, 2023
Deuterium Metabolic Imaging to Assess Radiotherapy Changes in
Not yet recruiting
- Glioblastoma Multiforme
- Deuterium metabolic imaging
-
Aarhus, DenmarkAarhus University
Jun 6, 2023
Post-operative Pain Trial (Dextromethorphan Hydrobromide, Placebo)
Recruiting
- Post-operative Pain
- Dextromethorphan Hydrobromide
- Placebo
-
Los Angeles, CaliforniaKeck School of Medicine of USC
Dec 12, 2022
Agitation in Patients With Dementia of the Alzheimer's Type Trial in Worldwide (AVP-786, Placebo)
Recruiting
- Agitation in Patients With Dementia of the Alzheimer's Type
- AVP-786
- Placebo
-
Birmingham, Alabama
- +82 more
Aug 23, 2022
Covid19, Amyotrophic Lateral Sclerosis Trial in Charlotte
Recruiting
- Covid19
- Amyotrophic Lateral Sclerosis
-
Charlotte, North CarolinaNeurosciences Institute, Neurology - Charlotte
Jan 24, 2023
Sarcopenia Trial in Gainesville (Resistance Training, Successful Aging)
Active, not recruiting
- Sarcopenia
- Resistance Training
- Successful Aging
-
Gainesville, Florida
- +1 more
Jun 30, 2022
Agitation in Patients With Dementia of the Alzheimer's Type Trial in Worldwide (AVP-786, Placebo)
Recruiting
- Agitation in Patients With Dementia of the Alzheimer's Type
- AVP-786
- Placebo
-
Phoenix, Arizona
- +73 more
Jul 22, 2022
Fibromyalgia Trial in Birmingham (Dextromethorphan, Placebo)
Completed
- Fibromyalgia
- Dextromethorphan
- Placebo
-
Birmingham, AlabamaUniversity of Alabama of Birmingham
Aug 3, 2022
Healthy Subjects Trial in Suzhou (Itraconazole, IBI351, Dextromethorphan)
Not yet recruiting
- Healthy Subjects
- Itraconazole
- +2 more
-
Suzhou, Jiangsu, ChinaThe First Affiliated Hospital of Suzhou University
Jan 25, 2023
ADHD Trial (Dextromethorphan)
No longer available
- Attention Deficit Hyperactivity Disorder
- (no location specified)
Apr 25, 2022
Chemo-induced Peripheral Neuropathy Trial in Clermont-Ferrand (Dextromethorphan)
Terminated
- Chemotherapy-induced Peripheral Neuropathy
-
Clermont-Ferrand, FranceLise LACLAUTRE
Oct 6, 2022
Agitation in Patients With Dementia of the Alzheimer's Type Trial in United States (AVP-786, Placebo)
Completed
- Agitation in Patients With Dementia of the Alzheimer's Type
- AVP-786
- Placebo
-
Phoenix, Arizona
- +79 more
Jan 29, 2020